Design, synthesis, and evaluation of compounds capable of reducing Pseudomonas aeruginosa virulence

Mohammad Anwar Hossain, Narsimha Sattenapally, Hardik I. Parikh, Wei Li, Kendra P. Rumbaugh, Nadezhda A. German

Research output: Contribution to journalArticlepeer-review

19 Scopus citations


Anti-virulence approaches in the treatment of Pseudomonas aeruginosa (PA)-induced infections have shown clinical potential in multiple in vitro and in vivo studies. However, development of these compounds is limited by several factors, including the lack of molecules capable of penetrating the membrane of gram-negative organisms. Here, we report the identification of novel structurally diverse compounds that inhibit PqsR and LasR-based signaling and diminish virulence factor production and biofilm growth in two clinically relevant strains of P. aeruginosa. It is the first report where potential anti-virulent agents were evaluated for inhibition of several virulence factors of PA. Finally, co-treatment with these inhibitors significantly reduced the production of virulence factors induced by the presence of sub-inhibitory levels of ciprofloxacin. Further, we have analyzed the drug-likeness profile of designed compounds using quantitative estimates of drug-likeness (QED) and confirmed their potential as hit molecules for further development.

Original languageEnglish
Article number111800
JournalEuropean Journal of Medicinal Chemistry
StatePublished - Jan 1 2020


  • Anti-virulence
  • Ciprofloxacin
  • P. aeruginosa
  • Quorum sensing


Dive into the research topics of 'Design, synthesis, and evaluation of compounds capable of reducing Pseudomonas aeruginosa virulence'. Together they form a unique fingerprint.

Cite this